scholarly article | Q13442814 |
P50 | author | Shalender Bhasin | Q64495451 |
P2093 | author name string | Tina Davidson | |
Carmen Martinez | |||
Colleen Azen | |||
E Todd Schroeder | |||
Thomas W Storer | |||
Indrani Sinha-Hikim | |||
Fred R Sattler | |||
S Victoria Jaque | |||
Michael Terk | |||
Atam Singh | |||
P2860 | cites work | Strength and cross-sectional area of human skeletal muscle | Q24531218 |
A and B forms of the androgen receptor are present in human genital skin fibroblasts | Q24561594 | ||
Effects of strength training and immobilization on human muscle fibres | Q28109419 | ||
Epidemiology of sarcopenia among the elderly in New Mexico | Q28268502 | ||
Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension | Q32021093 | ||
Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men. | Q33637762 | ||
Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78-84 and 23-32 yr olds | Q33897075 | ||
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. | Q33910338 | ||
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels | Q33943952 | ||
Testosterone dose-response relationships in healthy young men. | Q33955919 | ||
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. | Q34062583 | ||
Androgen abuse by athletes | Q34163640 | ||
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? | Q34289131 | ||
Proof of the effect of testosterone on skeletal muscle | Q34296145 | ||
Clinical review 134: The endocrinology of prostate cancer | Q34335839 | ||
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis | Q39369061 | ||
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms | Q39593353 | ||
Androgens and aging in men. | Q40773494 | ||
Depressive symptoms and physical decline in community-dwelling older persons | Q45117826 | ||
Appendicular skeletal muscle mass: effects of age, gender, and ethnicity | Q46956858 | ||
Predictors of skeletal muscle mass in elderly men and women. | Q50644590 | ||
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. | Q50961169 | ||
How good a marker is insulin level for insulin resistance? | Q51600914 | ||
Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. | Q52042770 | ||
Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. | Q55060303 | ||
Depressed Mood and Body Mass Index as Predictors of Muscle Strength Decline in Old Men | Q57416037 | ||
Human quadriceps cross-sectional area, torque and neural activation during 6 months strength training | Q58809030 | ||
P433 | issue | 1 | |
P304 | page(s) | E120-8 | |
P577 | publication date | 2002-09-24 | |
P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
P1476 | title | Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. | |
P478 | volume | 284 |
Q36529623 | 25(OH) vitamin D is associated with greater muscle strength in healthy men and women |
Q35784175 | Age-related changes in testosterone and the role of replacement therapy in older men. |
Q82944004 | Alanine aminotransferase regulation by androgens in non-hepatic tissues |
Q44361952 | Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies |
Q36842367 | Body composition, metabolic syndrome and testosterone in ageing men. |
Q36978134 | Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. |
Q35672930 | Current concepts in anabolic-androgenic steroids |
Q36583321 | Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients |
Q64080273 | Effect of vitamin D supplementation on upper and lower limb muscle strength and muscle power in athletes: A meta-analysis |
Q49764027 | Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men. |
Q33222142 | Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis |
Q35032969 | Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. |
Q37690775 | Emerging cardiometabolic complications of androgen deprivation therapy |
Q46244145 | Evaluation of hand functions in women with polycystic ovary syndrome |
Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
Q92556838 | Metabolic Disorders and Male Hypogonadotropic Hypogonadism |
Q35667540 | Regulation of body composition by androgens |
Q35188685 | Sex hormones and male health: effects on components of the frailty syndrome |
Q37212304 | Testosterone and growth hormone improve body composition and muscle performance in older men. |
Q38485746 | Testosterone and obesity |
Q28295533 | Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices |
Q36233399 | Testosterone supplementation in the aging male: which questions have been answered? |
Q46629445 | The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women |
Q24561868 | The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men |
Q34975803 | The use of anabolic steroids as a strategy in reversing denervation atrophy after delayed nerve repair |
Q37573464 | Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia |
Search more.